Generate a tailored SOP for Dr. Daniel Tenen. Improve your application with a focused, well-structured draft.
Daniel G. Tenen, M.D., is the head of the Blood Program at the Harvard Stem Cell Institute and a Professor of Medicine at Harvard Medical School. He serves as a Distinguished Professor in the Department of Medicine at the National University of Singapore and as the Director of the Cancer Science Institute of Singapore. His research primarily focuses on transcription factors, gene regulation, and the roles of these elements in normal differentiation and cancer. He has made significant contributions, establishing transcription factors' roles in myeloid cell differentiation and the disruption of these pathways leading to leukemia and lung cancer. Dr. Tenen was born and raised in Los Angeles, where he received his B.A. from the University of California, Los Angeles in 1967, and later earned his M.D. from Harvard Medical School in 1975. Following his medical training in Internal Medicine at Brigham & Women's Hospital and Medical Oncology at Dana Farber Cancer Institute, he undertook postdoctoral research in David Livingston's laboratory at Dana Farber. In 1984, he established his own independent lab at Beth Israel Deaconess Medical School and later at the Cancer Science Institute of Singapore in 2008. His lab explores transcription factors' regulatory roles, signaling transduction pathways, and the implications for therapeutics in cancer treatment.
Harvard Medical School • Boston, MA
Leading research in the Blood Program focusing on cancer and hematopoiesis.
Cancer Science Institute of Singapore • Singapore
Oversees research programs related to cancer science.
Administered by the Division of Medical Sciences (DMS). GRE is not required and will not be considered for BBS, Immunology, and Neuroscience.